Did a Permissive Scientific Culture Encourage the ‘CRISPR babies’ experiment?
By Donna Dickenson, Marcy Darnovsky,
Nature Biotechnology
| 03. 15. 2019
To the Editor — The claim last November by He Jiankui to have engineered the first CRISPR-edited babies has ignited voluble condemnation from scientists worldwide. What, then, made this rogue researcher think that his ‘achievement’ would be welcomed? One possible factor is that He claimed that he was influenced by the words and actions of key US and UK scientists. He attended and was an invited speaker at several meetings about gene editing, including several focused on the ethical acceptability of human germline modification1. And he explicitly cited the 2017 US National Academies of Science report as support for what he did2.
The Nuffield Council on Bioethics in the UK also issued a report in July 20183. Notably, it concludes that germline genome editing could be permissible under certain circumstances. More strongly, it moves beyond the merely permissible to the ethically obligatory, saying in its final section (paragraph 5.2) that “there are moral reasons to continue with the present lines of research and to secure the conditions under which heritable genome editing would be...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...